For instance, RIPK1 kinase activity can modulate NF‐κB and MAPK pathways, influencing cytokine production.[12, 22] Intriguingly, the JAK1‐STAT3 axis, a canonical pathway activated by cytokines like IL‐6, has been linked to CXCL1 transcription in cancers.[23, 24] Yet, whether RIPK1 interacts with JAK1‐STAT3 to drive chemokine expression in AECs remains unexplored. The gene discussed is JAK1; the disease is cancer.